Atlas Venture Opportunity Fund II, L.P.

Explore the complete record of transactions filed by Atlas Venture Opportunity Fund II, L.P.. Officer active across 1 company, notably Day One Biopharmaceuticals, Inc.. Cumulatively, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €10.9m. History available since 17 June 2022. The latest transaction was disclosed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.